- Home
- BTBD vs BFRI Comparison
BTBD vs BFRI Comparison
Compare BTBD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTBD
- BFRI
- Stock Information
- Founded
- BTBD 1987
- BFRI 1997
- Country
- BTBD United States
- BFRI United States
- Employees
- BTBD N/A
- BFRI N/A
- Industry
- BTBD Restaurants
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- BTBD Consumer Discretionary
- BFRI Health Care
- Exchange
- BTBD Nasdaq
- BFRI Nasdaq
- Market Cap
- BTBD 11.3M
- BFRI 10.6M
- IPO Year
- BTBD 2021
- BFRI 2021
- Fundamental
- Price
- BTBD $1.76
- BFRI $1.03
- Analyst Decision
- BTBD
- BFRI Strong Buy
- Analyst Count
- BTBD 0
- BFRI 1
- Target Price
- BTBD N/A
- BFRI $2.75
- AVG Volume (30 Days)
- BTBD 171.2K
- BFRI 99.6K
- Earning Date
- BTBD 11-12-2025
- BFRI 11-13-2025
- Dividend Yield
- BTBD N/A
- BFRI N/A
- EPS Growth
- BTBD N/A
- BFRI N/A
- EPS
- BTBD N/A
- BFRI N/A
- Revenue
- BTBD $14,533,449.00
- BFRI $39,188,000.00
- Revenue This Year
- BTBD N/A
- BFRI $9.70
- Revenue Next Year
- BTBD N/A
- BFRI $12.58
- P/E Ratio
- BTBD N/A
- BFRI N/A
- Revenue Growth
- BTBD 1.58
- BFRI 11.20
- 52 Week Low
- BTBD $1.00
- BFRI $0.54
- 52 Week High
- BTBD $5.60
- BFRI $1.87
- Technical
- Relative Strength Index (RSI)
- BTBD 46.73
- BFRI 51.02
- Support Level
- BTBD $1.74
- BFRI $1.00
- Resistance Level
- BTBD $2.10
- BFRI $1.15
- Average True Range (ATR)
- BTBD 0.15
- BFRI 0.07
- MACD
- BTBD -0.00
- BFRI 0.00
- Stochastic Oscillator
- BTBD 18.37
- BFRI 40.00
About BTBD BT Brands Inc.
BT Brands Inc operates and owns a fast-food restaurant called Burger Time. The company also operates in Minnesota as a franchisee of Dairy Queen. It offers a variety of burgers and other affordably priced foods such as chicken sandwiches, pulled pork sandwiches, chicken chunks, side dishes, and soft drinks.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.